GlassScriptPhysician profile
Brian Michael Goodman
NPI 1740453893
$18,527.63
in general payments reported to CMS, 2019-2025
20 companies · $12K in 2025
The $12K reported for 2025 was more than what 90% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,694 · 2020: $128 · 2021: $403 · 2022: $293 · 2023: $304 · 2024: $141 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,500 · Travel and Lodging: $5,374 · Food and Beverage: $1,136.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,500.00 |
| Travel and Lodging | $5,374.26 |
| Food and Beverage | $1,136.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,845.21 | 2019-2025 | |
| Pinnacle Biologics, INC | $4,988.70 | 2019-2021 | |
| Medical Device Business Services, INC. | $4,527.49 | 2022-2025 | Monarch |
| Ethicon INC. | $301.38 | 2025 | Monarch Platform |
| Zimmer Biomet Holdings, INC. | $280.97 | 2023 | Advantagerib |
| Lexington Medical, INC. | $125.74 | 2025 | Aeon Endostapler & Echelon Flex Powered Stapler |
| Solventum Corporation | $72.05 | 2025 | Promogran Prisma, Activ.A.C. |
| Merck Sharp & Dohme LLC | $55.08 | 2024-2025 | Keytruda |
| Peerless Surgical INC. | $49.64 | 2025 | |
| Atricure, INC. | $41.80 | 2024-2025 | Atriclip Laa Exclusion System |
| Polynovo North America LLC | $33.48 | 2025 | Novosorb Btm |
| Ambu INC. | $32.41 | 2025 | |
| Ethicon US, LLC | $27.95 | 2021 | |
| Davol INC. | $26.55 | 2020 | |
| Medtronic, INC. | $25.76 | 2025 | Illumisite |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $23.07 | 2023 | Matrixrib |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.70 | 2025 | Lifevest |
| Smith+Nephew, INC. | $20.82 | 2024 | Collagenase Santyl |
| Octapharma USA, INC. | $13.89 | 2025 | Fibryga |
| Kerecis Limited | $12.94 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Goodman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.